New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

By Oculis Holding AG | June 03, 2025, 5:00 PM

Oculis Holding AG

ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company.

Attachments

Mentioned In This Article

Oculis Holding AG

Latest News

Oct-14	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Oct-14	Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025 OCS GlobeNewswire
Oct-10	Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock? OCS Zacks
Oct-08	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Oct-06	Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy OCS GlobeNewswire
Sep-26	Oculis Publishes Notification of Transactions by Person Discharging Managerial Responsibilities OCS GlobeNewswire
Sep-23	Strength Seen in Oculis Holding AG (OCS): Can Its 6.7% Jump Turn into More Strength? OCS Zacks
Sep-22	Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS OCS GlobeNewswire
Sep-09	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Sep-04	Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025 OCS GlobeNewswire
Sep-03	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Sep-01	Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences OCS GlobeNewswire
Aug-28	Oculis to Participate in Upcoming September Investor Conferences OCS GlobeNewswire
Aug-25	Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors OCS GlobeNewswire
Aug-21	Oculis Holding AG (OCS) Reports Q2 Loss, Beats Revenue Estimates OCS Zacks

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.